Autonomous AI Physiotherapist Gets NHS Green Light and $12.5M Series A
Flok Health, a Cambridge-based startup, has raised $12.5 million in an oversubscribed Series A round to scale its AI physiotherapist. The twist: the AI is approved to triage, treat, and discharge NHS patients without any human clinician in the loop. That's a first in Europe.
The round was led by AlbionVC, with participation from existing investors Eka VC and Form Ventures, and new investor Mercia Ventures. Flok will use the funds to expand its back-pain service across the UK and launch three new care pathways: hip pain, knee pain, and women's pelvic health — all due this year.
Regulatory Standing Sets Flok Apart
Flok is the first AI system in Europe to earn Class IIa medical device certification for autonomous delivery of full care pathways. It's also the only digital musculoskeletal service approved as a healthcare provider by the UK's Care Quality Commission (CQC). These approvals mean it can operate without human oversight — a line most AI health tools won't cross.
The AI doesn't use an animated avatar. Instead, it manipulates real video footage of a human physiotherapist to simulate a live appointment that responds in real time to patient speech and movement. The goal: preserve the feeling of a clinician-led session while the AI handles clinical reasoning.
Real-World Results
Flok's back-pain service is already available to over 2.4 million NHS patients across eleven areas, with no waiting list. In one English trust, more than 80% of patients rated the AI clinic "as good or better than" in-person physiotherapy. The same trust saved an average of 856 hours of clinical time per month — freeing physiotherapists for complex cases.
Low back pain is the leading cause of disability worldwide. Over 390,000 people sit on musculoskeletal (MSK) waiting lists in England alone. Flok's CEO, Finn Stevenson, a former medic and rower, co-founded the company with software engineer Ric da Silva (ex-CMR Surgical). Stevenson frames the mission as closing a supply-demand gap that hiring more clinicians alone can't fix.
Technical Architecture
The core engineering challenge was building a system that feels like a real appointment. Flok's AI uses a combination of computer vision to analyze patient movement, natural language processing to understand speech, and a clinical reasoning engine that follows NHS guidelines. The video of a human physiotherapist is dynamically edited in real-time — lip-syncing, gestures, and gaze — to match the AI's responses. This avoids the uncanny valley of avatars while maintaining trust.
The system runs on cloud infrastructure with HIPAA-level security (though the NHS has its own standards). Patient data is encrypted at rest and in transit. The AI model was trained on thousands of hours of physiotherapy sessions, augmented with synthetic data for edge cases.
The $12.5M Bet
Flok's Series A is a bet that what worked for back pain will work for other MSK conditions. Hip, knee, and pelvic-health pathways are new ground. The regulatory approval Flok holds is pathway-specific — each new condition will require separate validation.
For developers, this is a case study in building regulated AI products. Flok didn't just build a chatbot; it navigated Class IIa medical device certification, CQC registration, and NHS data governance. That's years of work and millions in compliance costs — but the barrier to entry also protects their moat.
What's Next
Flok will deploy the new pathways across the UK this year. If the metrics hold — 80% patient satisfaction, 856 hours saved per month per trust — the autonomous physiotherapist could become a standard NHS offering. For developers, the takeaway is clear: AI can replace entire clinical workflows when the regulatory framework catches up. Flok is proof it's possible.
If you're building for healthcare, study Flok's approach to regulatory approval as a product feature, not an afterthought. The technical architecture is impressive, but the real innovation is the trust infrastructure.
